Evidence map›Paper›PMID 40644623›Full record

ArticleBlood advances2025

Ibrutinib increases miR-181a/b in leukemic cells from patients with chronic lymphocytic leukemia.

Alice Ramassone, Sara Pagotto, Mirco Di Marco, Mohammad Mamunur Rashid, Carola Di Camillo, Fabiana Palmiero, Idanna Innocenti, Francesco Autore, Annamaria Tomasso, Luca Laurenti and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Alice RamassoneDepartment of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.ORCID 0000-0002-5373-2024
Sara PagottoDepartment of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.ORCID 0000-0003-2457-6648
Mirco Di MarcoCenter for Advanced Studies and Technology, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Mohammad Mamunur RashidCenter for Advanced Studies and Technology, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Carola Di CamilloDepartment of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Fabiana PalmieroCenter for Advanced Studies and Technology, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.
Idanna InnocentiFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Francesco AutoreFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID 0000-0002-7868-7469
Annamaria TomassoFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Luca LaurentiFondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.ORCID 0000-0002-8327-1396
Rosa VisoneDepartment of Medical, Oral and Biotechnological Sciences, "G. d'Annunzio" University of Chieti-Pescara, Chieti, Italy.ORCID 0000-0002-4993-0220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40644623
PMCPMC12506510

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.